Journal of Ophthalmology · 2016 · 51 citations · 31 references
Veterinary MedicineOphthalmologySurgeryClinical OptometryEyelid DisordersOcular DiseaseEye ConditionsEye DiseaseEyelid DiseaseEyelid Gland DisordersEyelid Margin DisordersOcular Surface DiseaseLid Margin IrregularityMeibomian Gland AtrophyMeibomian Gland Function AssessmentMeibomian GlandsOcular Surface Meibomian Gland DysfunctionOcular SymptomsSystemic Disease HistoryTear Film Dysfunction
Purpose . The aim of this study was to investigate the relationships between MGL and ocular symptoms, several systemic conditions, and key markers of ocular surface health. Methods . We included into the study 91 healthy volunteers between the ages of 20 and 77 years. We analyzed meibomian gland morphology, function, and lid margin alterations. We correlated our findings with self-reported ocular symptoms, systemic medical history, lifestyle factors, and tear film abnormalities. Results . We observed that a high ocular surface disease index, a history of either chalazion or hordeolum, experience of puffy eyelids upon waking, and foreign body sensation all appeared to be predictors of an abnormal meiboscore after adjusting for age and sex (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0.0007</mml:mn></mml:math>;<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0.001</mml:mn></mml:math>;<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0.02</mml:mn></mml:math>;<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0.001</mml:mn></mml:math>, resp.). Multivariate logistic regression model including age and sex showed that there were three independent predictors of abnormal meiboscore: older age (OR = 1.03, 95% CI = 1.01–1.04 per year,<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0.006</mml:mn></mml:math>), postmenopausal hormone therapy (OR = 4.98, 95% CI = 1.52–16.30,<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0.007</mml:mn></mml:math>), and the use of antiallergy drugs (OR = 5.85, 95% CI = 2.18–15.72,<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn fontstyle="italic">0.0004</mml:mn></mml:math>). Conclusion . Our findings extend current knowledge on the pathophysiology of MGL.
31
World Medical Association Declaration of Helsinki
JAMA · 2013 · 29.4K citations
Hormone Replacement Therapy and Dry Eye Syndrome
Debra A. Schaumberg · JAMA · 2001 · 419 citations · Full text
The Contribution of Meibomian Disease to Dry Eye
Anthony J. Bron, John M. Tiffany · The Ocular Surface · 2004 · 337 citations